India and Uzbekistan are set to significantly boost bilateral trade, aiming to double it within three years. Discussions at the recent Inte...

The EU offers the biggest long-term opportunity for Indian medical device makers, while the UK has more immediate strategic value, says AiM...

India's AI and manufacturing push is reshaping job market, with engineers, technical support professionals and infrastructure roles seeing ...

The Indian Pharmaceutical Alliance believes tariffs alone will not build US generic drug manufacturing. Broader reforms are needed for fair...

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...

Five young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...

When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...

Indian employees can anticipate salary increments of 8.6% to 10.2% in FY2026-27, with EV infrastructure, fintech, and healthcare sectors le...

Corporate India anticipates salary increments between 8.6% and 10.2% this financial year, driven by demand for skilled talent in high-growt...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Over 67,000 cases of Power Stick deodorant sold at major retailers like Walmart, Amazon, and Dollar Tree have been voluntarily recalled. Th...

Union minister, Mansukh Mandaviya, has told representatives of the pharmaceutical industry that Schedule M, which requires adherence to goo...

"There will be no bargain on quality," Health Minister Mansukh Mandaviya told media on the sidelines of the 8th Global Pharmaceutical Quali...

CILICANT has become one of the world’s trusted brands in active pharmaceutical packaging. The company manufactures a range of high-quality ...

The US health regulator said its investigator "identified significant violations of current good manufacturing practice regulations for fin...

The warning letter follows inspection of the Halol facility in September 2014 by US Food and Drug Administration (USFDA) inspectors.

"The $ 25 billion target, however, for pharma exports in 2013-14 would be a challenging task in view of global slowdown"